Trailing-twelve-month (TTM) revenue is $10.15 Billion with a year-over-year growth of +6.21%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,938,142,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $2,244,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $2,331,221,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-04 |
| Q2 FY2026Period ended 2026-06-30 | $2,640,544,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-03 |
| TTM revenue | $10,154,307,000 |
Current P/S: $6,482,633,200 market capitalization ÷ $10,154,307,000 TTM revenue = 0.64x.
Market capitalization source: FMP quote. Quote observed 2026-09-18T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $2.64B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:50.399Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Onboard and other | $413M | $255M | $1.6B | $2.8B | $3.1B | $3.1B |
| Passenger ticket | $867M | $393M | $3.3B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $153M | $6M | $115M | $533M | $779M | $997M |
| Europe | $28M | $212M | $1.6B | $2.8B |
$10.15B
$10.15 Billion
+6.21%
vs. $9.56B a year ago (TTM)
+236.47%
5 Year compound annual growth rate
1 Year
+6.21%
3 Year
+12.34%
5 Year
+236.47%
10 Year
+8.27%
15 Year
+10.80%
20 Year
+9.45%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $9.83B | +$347.94M | +3.67% |
| 2024 | $9.48B | +$929.73M | +10.87% |
| 2023 | $8.55B | +$3.71B | +76.51% |
| 2022 | $4.84B | +$4.20B | +647.51% |
| 2021 | $647.99M | ($631.92M) | (49.37%) |
| 2020 |
TTM Growth
+6.21%
3-Year CAGR
+12.34%
5-Year CAGR
+236.47%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-19T00:15:50.399Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $6.4B |
| $6.7B |
| $2.9B |
| North America | $960M | $424M | $3.1B | $5.0B | $5.3B | $5.6B |
|---|
| Other Country | $139M | $6M | $94M | $259M | $346M | $283M |
|---|
| $1.28B |
| ($5.18B) |
| (80.19%) |
| 2019 | $6.46B | +$407.25M | +6.73% |
| 2018 | $6.06B | +$658.95M | +12.21% |
| 2017 | $5.40B | +$521.84M | +10.71% |
| 2016 | $4.87B | +$529.29M | +12.18% |
